The type I interferonopathies comprise a heterogenous group of monogenic diseases associated with a constitutive activation of type I interferon signaling.The elucidation of the genetic causes of this group of diseases revealed an alteration of nucleic acid processing and signaling.ADAR1 is among the genes found mutated in patients with this type of disorders.This enzyme catalyzes the hydrolytic deamination of adenosines in inosines within a double-stranded RNA target (RNA editing of A to I). This RNA modification is widespread in human cells and deregulated in a variety of human diseases, ranging from cancers to neurological abnormalities.In this review, we briefly summarize the knowledge about the RNA editing alterations occurring in patients with mutations in ADAR1 gene and how these alterations might cause the inappropriate IFN activation.

Frassinelli, L., Galardi, S., Ciafre, S.a., Michienzi, A. (2021). RNA editing in interferonopathies. In RNA editing (pp. 269-286). Humana Press [10.1007/978-1-0716-0787-9_16].

RNA editing in interferonopathies

Frassinelli L.;Galardi S.;Ciafre S. A.;Michienzi A.
2021-01-01

Abstract

The type I interferonopathies comprise a heterogenous group of monogenic diseases associated with a constitutive activation of type I interferon signaling.The elucidation of the genetic causes of this group of diseases revealed an alteration of nucleic acid processing and signaling.ADAR1 is among the genes found mutated in patients with this type of disorders.This enzyme catalyzes the hydrolytic deamination of adenosines in inosines within a double-stranded RNA target (RNA editing of A to I). This RNA modification is widespread in human cells and deregulated in a variety of human diseases, ranging from cancers to neurological abnormalities.In this review, we briefly summarize the knowledge about the RNA editing alterations occurring in patients with mutations in ADAR1 gene and how these alterations might cause the inappropriate IFN activation.
2021
Settore BIO/13 - BIOLOGIA APPLICATA
Settore BIO/11
English
Rilevanza internazionale
Capitolo o saggio
ADAR1
Double-stranded RNAs
Innate immunity
Interferonopathies
RNA editing
Type I interferon
Frassinelli, L., Galardi, S., Ciafre, S.a., Michienzi, A. (2021). RNA editing in interferonopathies. In RNA editing (pp. 269-286). Humana Press [10.1007/978-1-0716-0787-9_16].
Frassinelli, L; Galardi, S; Ciafre, Sa; Michienzi, A
Contributo in libro
File in questo prodotto:
File Dimensione Formato  
bok-978-1-0716-0787-9.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 9.28 MB
Formato Adobe PDF
9.28 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/278159
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 3
  • ???jsp.display-item.citation.isi??? ND
social impact